Respiratory Disease Testing Market: Demand and Forecast 2021 – 2027

Respiratory Disease Testing Market: Demand and Forecast 2021 – 2027

An upsurge in industrialization and urbanization, which has massively contributed to the elevating air pollution levels, will propel respiratory disease testing market. Significant rise in tobacco smoking around the world has propelled the respiratory disease cases worldwide, in turn stimulating the global market growth.

According to a report by Global Market Insights, Inc. respiratory disease testing market  is projected to witness a commendable growth during the forecast timeline.

Request for a sample copy of this report @  

Respiratory diseases are the ailments affecting lungs as well as other parts of the respiratory system, some of them being,  are asthma, chronic obstructive pulmonary disease, pneumonia, lung cancer and pulmonary fibrosis. The major factors leading to respiratory diseases are infections, smoking tobacco, second-hand tobacco smoke, radon, asbestos and other air pollutants.

Imaging test segment is likely to mark a notable growth on account of accelerating demand for imaging modalities due to the worldwide outbreak of novel coronavirus. These have proven to be extremely useful for identifying new cases of COVID-19, which will propel the respiratory disease testing industry growth. For instance, in Spain, chest X-ray was the first imaging method for the diagnosis of corona infection.

Moreover, rising incidences of lung cancer is also impelling the demand for imaging testing methods. According to the data released by WHO, 2018 recorded nearly 2.09 million cases of lung cancer worldwide.. Imaging test is very crucial for the diagnosis of lung cancer and also used during the treatment and after the treatment for getting the pictures of the organs. The most popular techniques are CT scan, X-Ray, PET and MRI.

Tuberculosis segment is expected to register a commendable growth over the forthcoming years owing to increasing prevalence across the developing economies such as Cambodia, South Africa, Congo, etc.

Request for customization @

Several industry players operational in the market are focused on developing technologically advanced solutions for tuberculosis testing in order to strengthen their foothold in the market. For instance, in 2019, Qiagen, one of the eminent names in the industry, announced the launch of a new solution QuantiFERON®-TB Access for diagnosis of latent tuberculosis prevailing in countries in Asia, Latin America and Africa having lower resources and higher burden of the disease. Reportedly, this product helped the company gain recognition from the Joint United Nations Programme on HIV/AIDS (UNAIDS).

Hospitals segment is estimated to witness a remarkable growth attributing to the availability of several imaging modalities with various mechanical tests. Further, medical tie-ups with hospitals will also contribute to the market growth.

Speaking of medical tie-ups, in 2020, a prominent medical device manufacturer in India- Omron Healthcare announced its collaboration with leading pharmaceutical company Lupin to develop facilities for respiratory disease management particularly for asthma and chronic obstructive pulmonary disease.  Apparently, through this collaboration, the two companies are planning to set up nebulization rooms in several hospitals offering screening, diagnosis, drug delivery, advanced devices, etc., under single facility.

Asia Pacific respiratory disease testing market is projected to register a substantial growth over the coming years owing to rising prevalence of respiratory disorders along with the introduction of favorable reimbursement policies in the region. Considering these growth attributes, China and India are expected to record maximum remunerations in the region.

Considering the daunting situation owing to   COVID-19 outbreak, countries around the world are demanding test kits for diagnosis of corona infection. India depicting third largest number of novel coronavirus cases in the world has urged the need for testing kits. Reportedly, the Indian Council of Medical Research (ICMR) has called for the quotations from manufacturers of kits for testing COVID-19 in order to expand coronavirus diagnostics in the country.

Partial Chapter of the Table of Content

Chapter 2.    Executive Summary

2.1. Global respiratory disease testing industry 360º synopsis, 2015 - 2026

2.1.1.    Business trends

2.1.2.    Test type trends

2.1.3.    Application trends

2.1.4.    End-use trends

2.1.5.    Regional trends

Chapter 3.    Global Respiratory Disease Testing Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1.    Growth drivers    Rising prevalence of COVID-19 infection    Increasing incidence of respiratory diseases    Surge in tuberculosis and hospital acquired infections    Technological advancements in imaging modalities

3.3.2.    Industry pitfalls & challenges    Rise in laboratory testing costs    Lack of awareness

3.4. Growth potential analysis

3.4.1. By test type

3.4.2.    By application

3.4.3.    By end-use

3.5. COVID-19 impact analysis

3.5.1.    Impact of COVID-19 on 10 major markets    Overview    U.S.    Canada    UK    Germany    Italy    Spain    France    India    China    Japan

3.5.2. Impact of COVID-19 on industry segments, by 10 major markets (2020)    Mechanical tests    Imaging tests    In-vitro diagnostic tests

3.5.3.    Impact of COVID-19 on industry value chain    Research and development    Manufacturing    Marketing    Supply

3.5.4.    Impact of COVID-19 on industry competition    Strategy    Distribution network    Product portfolio    Business growth

3.6. Porter’s analysis

3.7. Competitive landscape, 2019

3.7.1. Market structure

3.8. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @